Leukaemia: Don't let sleeping cells lie
Nature Reviews Cancer 17, 3 (2017).
doi:10.1038/nrc.2016.150
Author: M. Teresa Villanueva
In many patients with acute lymphoblastic leukaemia (ALL), most cells respond to chemotherapy but a minority show resistance and cause relapse with poor outcome. Using patient-derived xenograft models, Ebinger et al. identified a subpopulation of resistant and relapse-inducing cells with long-term dormancy and stemness
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: M. Teresa Villanueva Tags: Research Highlight Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Leukemia